Publications
19
Citations
342
Est. group size
—
Recurring co-author estimate
Active years
37
Publishing since 1989
Josh Richards conducts medical research spanning two distinct areas: the immunology of parasitic worm (helminth) infections and how they influence the immune signaling molecule IL-33, and clinical vision science including contact lenses and myopia (nearsightedness) control. The work combines laboratory studies of immune cells and molecules with clinical assessments of eye health and treatments. Some publications also address skin conditions such as psoriasis and their responses to biologic drugs.
Publication activity has grown over the past decade, rising from about one paper per year to a peak of five in 2024.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Vaccination against helminth IL-33 modulators permits immune-mediated parasite ejection
Cell Reports · 2025
- Metabolomic and functional analyses of small molecules secreted by intestinal nematodes in the activation of epithelial tuft cells
Metabolomics · 2025
- Radiometric and safety assessment of a ‘low‐level red‐light’ myopia control device
Ophthalmic and Physiological Optics · 2025
- Vaccination against helminth IL-33-modulators permits immune-mediated parasite ejection
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Can optical modelling predict clinical vision outcomes of myopia control contact lenses?
Contact Lens and Anterior Eye · 2024
- On‐eye centration of soft contact lenses
Ophthalmic and Physiological Optics · 2024
- The association between participant‐reported ratings of comfort, dryness and vision quality in soft contact lens wearers
Ophthalmic and Physiological Optics · 2024
- Inserting “OFF-to-ON” BODIPY Tags into Cytokines: A Fluorogenic Interleukin IL-33 for Real-Time Imaging of Immune Cells
ACS Central Science · 2023
- Characteristics of ‘super responders’ and ‘super nonresponders’ to first biologic monotherapy for psoriasis: a nested case–control study
British Journal of Dermatology · 2023
- Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis
JAMA Dermatology · 2022
- Suppression of airway allergic eosinophilia by <scp><i>Hp</i>‐TGM</scp>, a helminth mimic of <scp>TGF</scp>‐β
Immunology · 2022
- Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis
Journal of Investigative Dermatology · 2021
- A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine
Frontiers in Immunology · 2020
- A truncated form of HpARI stabilises IL-33, amplifying responses to the cytokine
bioRxiv (Cold Spring Harbor Laboratory) · 2020
- High resolution techniques: general discussion
Faraday Discussions · 2019
- Ophthalmic and Physiological Optics×5
- bioRxiv (Cold Spring Harbor Laboratory)×2
- JAMA Dermatology×1
- Frontiers in Immunology×1
- Journal of Investigative Dermatology×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile